Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Customer/Partner Service Surveys, 10648 [05-4160]
Download as PDF
<![CDATA[
10648
Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices
In 2001, when preparing the earlier
package for approval of the information
collection requirements in part 806,
FDA reviewed the reports of corrections
and removals submitted in the previous
3 years under part 7 (21 CFR part 7) (the
agency’s recall provisions). FDA has
determined that estimates of the
reporting burden in §§ 806.10 and
806.20 should be revised to reflect a
reduction of 29 percent for reports and
records submitted under part 7 due to
a decrease in recall actions. The time
needed to collect information has been
reduced by 4 hours per record due to
the implementation of a computerized
program for information collection
requirements in part 806.
Dated: February 25, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05–4159 Filed 3–3–05; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004N–0401]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Customer/Partner
Service Surveys
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by April 4,
2005.
OMB is still experiencing
significant delays in the regular mail,
including first class and express mail,
and messenger deliveries are not being
accepted. To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: Fumie Yokota, Desk Officer
for FDA, FAX: 202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Management
Programs (HFA–250), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–4659.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
ADDRESSES:
Customer/Partner Service Surveys—
(OMB Control Number 0910–0360)—
Extension
Under section 903 of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C.
393), FDA is authorized to conduct
research and public information
programs about regulated products and
responsibilities of the agency. Executive
Order 12862, entitled ‘‘Setting Customer
Service Standard,’’ directs Federal
agencies that ‘‘provide significant
services directly to the public’’ to
‘‘survey customers to determine the
kind and quality of services they want
and their level of satisfaction with
existing services.’’ FDA is seeking OMB
clearance to conduct a series of surveys
to implement Executive Order 12862.
Participation in the surveys is
voluntary. This request covers
customer/partner service surveys of
regulated entities, such as the following:
Food processors; cosmetic drug, biologic
and medical device manufacturers;
consumers; and health professionals.
The request also covers ‘‘partner’’ (State
and local governments) customer
service surveys.
FDA will use the information from
these surveys to identify strengths and
weaknesses in service to customers/
partners and to make improvements.
The surveys will measure timeliness,
appropriateness and accuracy of
information, courtesy, and problem
resolution in the context of individual
programs.
FDA projects that approximately 15
customer/partner service surveys will be
conducted per year, with a sample of
between 50 and 6,000 customers,
requiring an average of 18 minutes for
review and completion for each survey.
Some of these surveys will be repeats of
earlier surveys, for purposes of
monitoring customer/partner service
and developing long-term data.
In the Federal Register of September
16, 2004 (69 FR 55823), FDA published
a 60-day notice requesting public
comment on the information collection
provisions. No comments were received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
Type of Survey
No. of Respondents
Mail/telephone/fax/web-based
1There
Annual Frequency per
Response
15,000
Total Annual
Responses
1
15,000
Hours per Respondent
.30
Total Hours
4,500
are no capital costs or operating and maintenance costs associated with this collection of information.
Dated: February 25, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05–4160 Filed 3–3–05; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004N–0498]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Medical Devices; Device Tracking
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
VerDate jul<14>2003
19:07 Mar 03, 2005
Jkt 205001
PO 00000
Notice.
Frm 00058
Fmt 4703
Sfmt 4703
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by April 4,
2005.
OMB is still experiencing
significant delays in the regular mail,
including first class and express mail,
and messenger deliveries are not being
accepted. To ensure that comments on
ADDRESSES:
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 70, Number 42 (Friday, March 4, 2005)]
[Notices]
[Page 10648]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4160]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004N-0401]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Customer/Partner
Service Surveys
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by April
4, 2005.
ADDRESSES: OMB is still experiencing significant delays in the regular
mail, including first class and express mail, and messenger deliveries
are not being accepted. To ensure that comments on the information
collection are received, OMB recommends that written comments be faxed
to the Office of Information and Regulatory Affairs, OMB, Attn: Fumie
Yokota, Desk Officer for FDA, FAX: 202-395-6974.
FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of Management
Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-4659.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Customer/Partner Service Surveys--(OMB Control Number 0910-0360)--
Extension
Under section 903 of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 393), FDA is authorized to conduct research and public
information programs about regulated products and responsibilities of
the agency. Executive Order 12862, entitled ``Setting Customer Service
Standard,'' directs Federal agencies that ``provide significant
services directly to the public'' to ``survey customers to determine
the kind and quality of services they want and their level of
satisfaction with existing services.'' FDA is seeking OMB clearance to
conduct a series of surveys to implement Executive Order 12862.
Participation in the surveys is voluntary. This request covers
customer/partner service surveys of regulated entities, such as the
following: Food processors; cosmetic drug, biologic and medical device
manufacturers; consumers; and health professionals. The request also
covers ``partner'' (State and local governments) customer service
surveys.
FDA will use the information from these surveys to identify
strengths and weaknesses in service to customers/partners and to make
improvements. The surveys will measure timeliness, appropriateness and
accuracy of information, courtesy, and problem resolution in the
context of individual programs.
FDA projects that approximately 15 customer/partner service surveys
will be conducted per year, with a sample of between 50 and 6,000
customers, requiring an average of 18 minutes for review and completion
for each survey. Some of these surveys will be repeats of earlier
surveys, for purposes of monitoring customer/partner service and
developing long-term data.
In the Federal Register of September 16, 2004 (69 FR 55823), FDA
published a 60-day notice requesting public comment on the information
collection provisions. No comments were received.
FDA estimates the burden of this collection of information as
follows:
Table 1.--Estimated Annual Reporting Burden\1\
----------------------------------------------------------------------------------------------------------------
Annual Frequency per Total Annual Hours per
Type of Survey No. of Respondents Response Responses Respondent Total Hours
----------------------------------------------------------------------------------------------------------------
Mail/telephone/ 15,000 1 15,000 .30 4,500
fax/web-based
----------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.
Dated: February 25, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05-4160 Filed 3-3-05; 8:45 am]
BILLING CODE 4160-01-S
